UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$257M |
| 2 |
Microsoft
MSFT
|
+$214M |
| 3 |
Meta Platforms (Facebook)
META
|
+$212M |
| 4 |
Palo Alto Networks
PANW
|
+$180M |
| 5 |
Alibaba
BABA
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$224M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$212M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$156M |
| 4 |
Eli Lilly
LLY
|
+$123M |
| 5 |
Fortinet
FTNT
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.21% |
| 2 | Healthcare | 13.78% |
| 3 | Financials | 13.47% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Communication Services | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
1901
DELISTED
Everi Holdings
EVRI
| $743K | ﹤0.01% |
70,597
-3,418
| -5% | -$26K |
|
|
AVTA
1902
DELISTED
Avantax, Inc. Common Stock
AVTA
| $742K | ﹤0.01% |
22,230
+3,731
| +20% | +$109K |
|
|
QUOT
1903
DELISTED
Quotient Technology Inc
QUOT
| $741K | ﹤0.01% |
75,068
+24,043
| +47% | +$247K |
|
1904
Radware
RDWR
$1.19B
| $739K | ﹤0.01% |
28,300
-2,600
| -8% | -$63.4K |
|
1905
ArcBest
ARCB
$3.08B
| $738K | ﹤0.01% |
23,982
+8,082
| +51% | +$292K |
|
1906
Stoneridge
SRI
$213M
| $738K | ﹤0.01% |
25,576
+4,538
| +22% | +$124K |
|
|
HIFR
1907
DELISTED
InfraREIT, Inc.
HIFR
| $736K | ﹤0.01% |
35,111
+7,914
| +29% | +$168K |
|
1908
M/I Homes
MHO
$3.84B
| $736K | ﹤0.01% |
27,638
+9,743
| +54% | +$254K |
|
1909
E.W. Scripps
SSP
$304M
| $735K | ﹤0.01% |
35,012
-1,047
| -3% | -$20.8K |
|
1910
Scholastic
SCHL
$792M
| $732K | ﹤0.01% |
18,421
+2,184
| +13% | +$90.1K |
|
1911
Freshpet
FRPT
$3.22B
| $730K | ﹤0.01% |
17,250
| – | – |
|
|
SYKE
1912
DELISTED
SYKES Enterprises Inc
SYKE
| $728K | ﹤0.01% |
25,751
+11,705
| +83% | +$330K |
|
1913
Trupanion
TRUP
$1.18B
| $727K | ﹤0.01% |
22,207
+700
| +3% | +$19.9K |
|
|
CSGS
1914
DELISTED
CSG Systems International
CSGS
| $726K | ﹤0.01% |
17,168
+2,698
| +19% | +$104K |
|
|
MNTA
1915
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $725K | ﹤0.01% |
49,918
+8,215
| +20% | +$105K |
|
1916
AtriCure
ATRC
$2.11B
| $723K | ﹤0.01% |
26,995
-46
| -0.2% | -$1.4K |
|
1917
TTM Technologies
TTMI
$14.5B
| $723K | ﹤0.01% |
61,611
+14,342
| +30% | +$164K |
|
1918
Opko Health
OPK
$1.02B
| $719K | ﹤0.01% |
275,646
-24,943
| -8% | -$75.5K |
|
1919
GrafTech
EAF
$212M
| $719K | ﹤0.01% |
5,624
+2,030
| +56% | +$270K |
|
1920
AZZ Inc
AZZ
$4.54B
| $716K | ﹤0.01% |
17,492
+500
| +3% | +$22.1K |
|
1921
Extreme Networks
EXTR
$3.15B
| $714K | ﹤0.01% |
95,386
+21,530
| +29% | +$157K |
|
1922
Helios Technologies
HLIO
$2.76B
| $714K | ﹤0.01% |
+15,357
| New | +$614K |
|
1923
First Bancorp
FBNC
$2.68B
| $714K | ﹤0.01% |
20,527
+2,834
| +16% | +$104K |
|
|
ILPT
1924
Industrial Logistics Properties Trust
ILPT
$586M
| $713K | ﹤0.01% |
35,349
-98,184
| -74% | -$2.02M |
|
|
EBIX
1925
DELISTED
Ebix Inc
EBIX
| $710K | ﹤0.01% |
14,385
+8,406
| +141% | +$443K |
|
Similar funds
UBS AM's Q1 2019 Portfolio in Review
As of Q1 2019, UBS AM held 2,870 positions worth $135B, up 16% from $116B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q1 2019 filing shows 103 new, 1,731 increased, 679 reduced and 79 closed positions. Its largest new stake was Fox Class A: 1,047,931 shares worth $38.5M. The largest sale was PepsiCo, an estimated $224M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2019 buy was Fox Class A: 1,047,931 shares worth $38.5M.
- UBS AM added most to Procter & Gamble in Q1 2019, an estimated $257M increase.
- UBS AM's biggest Q1 2019 reduction was PepsiCo, cutting an estimated $224M.
- UBS AM fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $156M.
- UBS AM's ten largest holdings make up 19% of its $135B portfolio in Q1 2019.
- UBS AM opened 103 new positions and closed 79 in Q1 2019.
- UBS AM's portfolio value rose 16% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.